Skip to main content

12 March 2026

Last updated: Tuesday 10 March 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Genmab looks ahead to next phase of growth

Sunday 11 November 2018

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Why industry is investing in bispecific molecules

Wednesday 15 June 2016

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Organisations

Innovation and International Relationship
ETH Zürich
Noxxon Pharma AG
NDA Advisory Services Ltd
Prima BioMed Ltd
Cellular Dynamics International
Achilles Therapeutics Ltd
Diurnal Group Plc
Odlander, Fredrikson and Co AB
European Patent Office

Interviewees and Contributers

Jackie Iversen
Vincent Charlon
João Ribas and Morten Graugaard Døssing
Graham Burnett-Hall
Matthias Kramer
Francesco De Rubertis
Alastair Smith
Hervé Affagard
Christian Jørgensen
Marta Swierczynska

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

VoxCell appoints CCO

Saturday 28 February 2026

Qlaris Bio appoints board director

Saturday 28 February 2026

Clarametyx adds four experts to SAB

Saturday 28 February 2026

Enhanced Genomics appoints Katerina Leftheris to board

Saturday 28 February 2026

New COO at Qureight

Saturday 28 February 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form